Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...
Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...
NYSE:MDT) Medtronic announces CMS national coverage analysis for Symplicity(TM) Spyral Renal Denervation System ...